A citation-based method for searching scientific literature

Cristina López, Julio Delgado, Dolors Costa, Laura Conde, Gabriela Ghita, Neus Villamor, Alba Navarro, Maite Cazorla, Cándida Gómez, Amparo Arias, Concha Muñoz, Tycho Baumann, María Rozman, Marta Aymerich, Dolors Colomer, Francesc Cobo, Elías Campo, Armando López-Guillermo, Emili Montserrat, Ana Carrió. Genes Chromosomes Cancer 2012
Times Cited: 52







List of co-cited articles
550 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.
Xose S Puente, Magda Pinyol, Víctor Quesada, Laura Conde, Gonzalo R Ordóñez, Neus Villamor, Georgia Escaramis, Pedro Jares, Sílvia Beà, Marcos González-Díaz,[...]. Nature 2011
75

NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
Ilaria Del Giudice, Davide Rossi, Sabina Chiaretti, Marilisa Marinelli, Simona Tavolaro, Sara Gabrielli, Luca Laurenti, Roberto Marasca, Silvia Rasi, Marco Fangazio,[...]. Haematologica 2012
147
71

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.
Davide Rossi, Silvia Rasi, Giulia Fabbri, Valeria Spina, Marco Fangazio, Francesco Forconi, Roberto Marasca, Luca Laurenti, Alessio Bruscaggin, Michaela Cerri,[...]. Blood 2012
326
71

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.
Giulia Fabbri, Silvia Rasi, Davide Rossi, Vladimir Trifonov, Hossein Khiabanian, Jing Ma, Adina Grunn, Marco Fangazio, Daniela Capello, Sara Monti,[...]. J Exp Med 2011
451
71

NOTCH1 mutations in CLL associated with trisomy 12.
Veronica Balatti, Arianna Bottoni, Alexey Palamarchuk, Hansjuerg Alder, Laura Z Rassenti, Thomas J Kipps, Yuri Pekarsky, Carlo M Croce. Blood 2012
152
69

Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner, S Stilgenbauer, A Benner, E Leupolt, A Kröber, L Bullinger, K Döhner, M Bentz, P Lichter. N Engl J Med 2000
69

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.
Lili Wang, Michael S Lawrence, Youzhong Wan, Petar Stojanov, Carrie Sougnez, Kristen Stevenson, Lillian Werner, Andrey Sivachenko, David S DeLuca, Li Zhang,[...]. N Engl J Med 2011
808
61

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.
Víctor Quesada, Laura Conde, Neus Villamor, Gonzalo R Ordóñez, Pedro Jares, Laia Bassaganyas, Andrew J Ramsay, Sílvia Beà, Magda Pinyol, Alejandra Martínez-Trillos,[...]. Nat Genet 2011
731
57

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.
Davide Rossi, Marco Fangazio, Silvia Rasi, Tiziana Vaisitti, Sara Monti, Stefania Cresta, Sabina Chiaretti, Ilaria Del Giudice, Giulia Fabbri, Alessio Bruscaggin,[...]. Blood 2012
217
46

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.
N Villamor, L Conde, A Martínez-Trillos, M Cazorla, A Navarro, S Beà, C López, D Colomer, M Pinyol, M Aymerich,[...]. Leukemia 2013
136
46

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.
Davide Rossi, Alessio Bruscaggin, Valeria Spina, Silvia Rasi, Hossein Khiabanian, Monica Messina, Marco Fangazio, Tiziana Vaisitti, Sara Monti, Sabina Chiaretti,[...]. Blood 2011
285
42

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Michael Hallek, Bruce D Cheson, Daniel Catovsky, Federico Caligaris-Cappio, Guillaume Dighiero, Hartmut Döhner, Peter Hillmen, Michael J Keating, Emili Montserrat, Kanti R Rai,[...]. Blood 2008
38

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.
Dan A Landau, Scott L Carter, Petar Stojanov, Aaron McKenna, Kristen Stevenson, Michael S Lawrence, Carrie Sougnez, Chip Stewart, Andrey Sivachenko, Lili Wang,[...]. Cell 2013
983
38

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.
David Gonzalez, Pilar Martinez, Rachel Wade, Sarah Hockley, David Oscier, Estella Matutes, Claire E Dearden, Sue M Richards, Daniel Catovsky, Gareth J Morgan. J Clin Oncol 2011
196
36

TP53 mutation and survival in chronic lymphocytic leukemia.
Thorsten Zenz, Barbara Eichhorst, Raymonde Busch, Tina Denzel, Sonja Häbe, Dirk Winkler, Andreas Bühler, Jennifer Edelmann, Manuela Bergmann, Georg Hopfinger,[...]. J Clin Oncol 2010
402
36

Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.
Anna Schuh, Jennifer Becq, Sean Humphray, Adrian Alexa, Adam Burns, Ruth Clifford, Stephan M Feller, Russell Grocock, Shirley Henderson, Irina Khrebtukova,[...]. Blood 2012
226
34

Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.
Davide Rossi, Silvia Rasi, Valeria Spina, Alessio Bruscaggin, Sara Monti, Carmela Ciardullo, Clara Deambrogi, Hossein Khiabanian, Roberto Serra, Francesco Bertoni,[...]. Blood 2013
336
34

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.
David G Oscier, Matthew J J Rose-Zerilli, Nils Winkelmann, David Gonzalez de Castro, Belen Gomez, Jade Forster, Helen Parker, Anton Parker, Anne Gardiner, Andrew Collins,[...]. Blood 2013
169
34

Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up.
Thorsten Zenz, Alexander Kröber, Katrin Scherer, Sonja Häbe, Andreas Bühler, Axel Benner, Tina Denzel, Dirk Winkler, Jennifer Edelmann, Carsten Schwänen,[...]. Blood 2008
303
32

TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations.
T Zenz, D Vollmer, M Trbusek, J Smardova, A Benner, T Soussi, H Helfrich, M Heuberger, P Hoth, M Fuge,[...]. Leukemia 2010
100
30

Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells.
Emanuela Rosati, Rita Sabatini, Giuliana Rampino, Antonio Tabilio, Mauro Di Ianni, Katia Fettucciari, Andrea Bartoli, Stefano Coaccioli, Isabella Screpanti, Pierfrancesco Marconi. Blood 2009
226
30


Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.
Stephan Stilgenbauer, Andrea Schnaiter, Peter Paschka, Thorsten Zenz, Marianna Rossi, Konstanze Döhner, Andreas Bühler, Sebastian Böttcher, Matthias Ritgen, Michael Kneba,[...]. Blood 2014
363
28


Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial.
Thorsten Zenz, Sonja Häbe, Tina Denzel, Julia Mohr, Dirk Winkler, Andreas Bühler, Antonio Sarno, Silja Groner, Daniel Mertens, Raymonde Busch,[...]. Blood 2009
209
25

Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage.
Jitka Malcikova, Jana Smardova, Ludmila Rocnova, Boris Tichy, Petr Kuglik, Vladimira Vranova, Sona Cejkova, Miluse Svitakova, Hana Skuhrova Francova, Yvona Brychtova,[...]. Blood 2009
128
25


Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients.
R Gunnarsson, A Isaksson, M Mansouri, H Göransson, M Jansson, N Cahill, M Rasmussen, J Staaf, J Lundin, S Norin,[...]. Leukemia 2010
61
25

The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.
Davide Rossi, Michaela Cerri, Clara Deambrogi, Elisa Sozzi, Stefania Cresta, Silvia Rasi, Lorenzo De Paoli, Valeria Spina, Valter Gattei, Daniela Capello,[...]. Clin Cancer Res 2009
232
25

Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia.
Davide Rossi, Hossein Khiabanian, Valeria Spina, Carmela Ciardullo, Alessio Bruscaggin, Rosella Famà, Silvia Rasi, Sara Monti, Clara Deambrogi, Lorenzo De Paoli,[...]. Blood 2014
245
25

Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL.
Belinda Austen, Judith E Powell, Azra Alvi, Ian Edwards, Laura Hooper, Jane Starczynski, A Malcolm R Taylor, Christopher Fegan, Paul Moss, Tatjana Stankovic. Blood 2005
168
23

Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.
Tait D Shanafelt, Thomas E Witzig, Stephanie R Fink, Robert B Jenkins, Sarah F Paternoster, Stephanie A Smoley, Kimberly J Stockero, Danielle M Nast, Heather C Flynn, Renee C Tschumper,[...]. J Clin Oncol 2006
185
23

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.
R N Damle, T Wasil, F Fais, F Ghiotto, A Valetto, S L Allen, A Buchbinder, D Budman, K Dittmar, J Kolitz,[...]. Blood 1999
23

NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL.
Paolo Sportoletti, Stefano Baldoni, Laura Cavalli, Beatrice Del Papa, Elisabetta Bonifacio, Raffaella Ciurnelli, Alain Sylvin Bell, Ambra Di Tommaso, Emanuela Rosati, Barbara Crescenzi,[...]. Br J Haematol 2010
85
23

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia.
S Pospisilova, D Gonzalez, J Malcikova, M Trbusek, D Rossi, A P Kater, F Cymbalista, B Eichhorst, M Hallek, H Döhner,[...]. Leukemia 2012
153
23

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.
M Hallek, K Fischer, G Fingerle-Rowson, A M Fink, R Busch, J Mayer, M Hensel, G Hopfinger, G Hess, U von Grünhagen,[...]. Lancet 2010
23

Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome.
Davide Rossi, Silvia Rasi, Valeria Spina, Marco Fangazio, Sara Monti, Mariangela Greco, Carmela Ciardullo, Rosella Famà, Stefania Cresta, Alessio Bruscaggin,[...]. Br J Haematol 2012
75
23

Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
Lisa Kujawski, Peter Ouillette, Harry Erba, Chris Saddler, Andrzej Jakubowiak, Mark Kaminski, Kerby Shedden, Sami N Malek. Blood 2008
72
21

Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.
Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, Axel Benner, Elke Leupolt, Dirk Winkler, Alexander Kröber, Dirk Kienle, Peter Lichter, Hartmut Döhner. Haematologica 2007
163
21

Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.
T J Hamblin, Z Davis, A Gardiner, D G Oscier, F K Stevenson. Blood 1999
21

NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia.
L Mansouri, N Cahill, R Gunnarsson, K E Smedby, E Tjönnfjord, H Hjalgrim, G Juliusson, C Geisler, R Rosenquist. Leukemia 2013
60
21

SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.
S Jeromin, S Weissmann, C Haferlach, F Dicker, K Bayer, V Grossmann, T Alpermann, A Roller, A Kohlmann, T Haferlach,[...]. Leukemia 2014
169
21

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
P Baliakas, A Hadzidimitriou, L-A Sutton, D Rossi, E Minga, N Villamor, M Larrayoz, J Kminkova, A Agathangelidis, Z Davis,[...]. Leukemia 2015
214
21

Non-coding recurrent mutations in chronic lymphocytic leukaemia.
Xose S Puente, Silvia Beà, Rafael Valdés-Mas, Neus Villamor, Jesús Gutiérrez-Abril, José I Martín-Subero, Marta Munar, Carlota Rubio-Pérez, Pedro Jares, Marta Aymerich,[...]. Nature 2015
560
21

The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
Ulf Klein, Marie Lia, Marta Crespo, Rachael Siegel, Qiong Shen, Tongwei Mo, Alberto Ambesi-Impiombato, Andrea Califano, Anna Migliazza, Govind Bhagat,[...]. Cancer Cell 2010
590
19

Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
Rebeqa Gunnarsson, Larry Mansouri, Anders Isaksson, Hanna Göransson, Nicola Cahill, Mattias Jansson, Markus Rasmussen, Jeanette Lundin, Stefan Norin, Anne Mette Buhl,[...]. Haematologica 2011
76
19

Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
Peter Ouillette, Roxane Collins, Sajid Shakhan, Jinghui Li, Edward Peres, Lisa Kujawski, Moshe Talpaz, Mark Kaminski, Cheng Li, Kerby Shedden,[...]. Blood 2011
92
19

De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience.
Constantine S Tam, Tait D Shanafelt, William G Wierda, Lynne V Abruzzo, Daniel L Van Dyke, Susan O'Brien, Alessandra Ferrajoli, Susan A Lerner, Alice Lynn, Neil E Kay,[...]. Blood 2009
138
19

Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial.
Andrew R Pettitt, Richard Jackson, Stacey Carruthers, James Dodd, Susanna Dodd, Melanie Oates, Gillian G Johnson, Anna Schuh, Estella Matutes, Claire E Dearden,[...]. J Clin Oncol 2012
130
19

TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia.
Norafiza Zainuddin, Fiona Murray, Meena Kanduri, Rebeqa Gunnarsson, Karin E Smedby, Gunilla Enblad, Jesper Jurlander, Gunnar Juliusson, Richard Rosenquist. Leuk Res 2011
32
31


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.